Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aaron J. E., Francis R. M., Peacock M., Makins N. B. Contrasting microanatomy of idiopathic and corticosteroid-induced osteoporosis. Clin Orthop Relat Res. 1989 Jun;(243):294–305. [PubMed] [Google Scholar]
- Acanthamoeba keratitis. Lancet. 1988 Mar 26;1(8587):687–688. [PubMed] [Google Scholar]
- Bentz H., Nathan R. M., Rosen D. M., Armstrong R. M., Thompson A. Y., Segarini P. R., Mathews M. C., Dasch J. R., Piez K. A., Seyedin S. M. Purification and characterization of a unique osteoinductive factor from bovine bone. J Biol Chem. 1989 Dec 5;264(34):20805–20810. [PubMed] [Google Scholar]
- Dempster D. W. Bone histomorphometry in glucocorticoid-induced osteoporosis. J Bone Miner Res. 1989 Apr;4(2):137–141. doi: 10.1002/jbmr.5650040202. [DOI] [PubMed] [Google Scholar]
- Gennari C., Civitelli R. Glucocorticoid-induced osteoporosis. Clin Rheum Dis. 1986 Dec;12(3):637–654. [PubMed] [Google Scholar]
- Gluck O. S., Murphy W. A., Hahn T. J., Hahn B. Bone loss in adults receiving alternate day glucocorticoid therapy. A comparison with daily therapy. Arthritis Rheum. 1981 Jul;24(7):892–898. doi: 10.1002/art.1780240705. [DOI] [PubMed] [Google Scholar]
- Kyle V., Hazelman B. L. Stopping steroids in polymyalgia rheumatica and giant cell arteritis. BMJ. 1990 Feb 10;300(6721):344–345. doi: 10.1136/bmj.300.6721.344. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lindsay R. Fluoride and bone--quantity versus quality. N Engl J Med. 1990 Mar 22;322(12):845–846. doi: 10.1056/NEJM199003223221210. [DOI] [PubMed] [Google Scholar]
- Nielsen H. K., Charles P., Mosekilde L. The effect of single oral doses of prednisone on the circadian rhythm of serum osteocalcin in normal subjects. J Clin Endocrinol Metab. 1988 Nov;67(5):1025–1030. doi: 10.1210/jcem-67-5-1025. [DOI] [PubMed] [Google Scholar]
- Pak C. Y., Eun H. M., McArthur R. G., Yoon J. W. Association of cytomegalovirus infection with autoimmune type 1 diabetes. Lancet. 1988 Jul 2;2(8601):1–4. doi: 10.1016/s0140-6736(88)92941-8. [DOI] [PubMed] [Google Scholar]
- Peretz A., Praet J. P., Bosson D., Rozenberg S., Bourdoux P. Serum osteocalcin in the assessment of corticosteroid induced osteoporosis. Effect of long and short term corticosteroid treatment. J Rheumatol. 1989 Mar;16(3):363–367. [PubMed] [Google Scholar]
- Pocock N. A., Eisman J. A., Dunstan C. R., Evans R. A., Thomas D. H., Huq N. L. Recovery from steroid-induced osteoporosis. Ann Intern Med. 1987 Sep;107(3):319–323. doi: 10.7326/0003-4819-107-2-319. [DOI] [PubMed] [Google Scholar]
- Reid D. M. Corticosteroid-induced osteoporosis and hormone implants. Lancet. 1989 Mar 11;1(8637):563–563. doi: 10.1016/s0140-6736(89)90109-8. [DOI] [PubMed] [Google Scholar]
- Reid D. M., Nicoll J. J., Smith M. A., Higgins B., Tothill P., Nuki G. Corticosteroids and bone mass in asthma: comparisons with rheumatoid arthritis and polymyalgia rheumatica. Br Med J (Clin Res Ed) 1986 Dec 6;293(6560):1463–1466. doi: 10.1136/bmj.293.6560.1463. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Reid I. R., King A. R., Alexander C. J., Ibbertson H. K. Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD). Lancet. 1988 Jan 23;1(8578):143–146. doi: 10.1016/s0140-6736(88)92721-3. [DOI] [PubMed] [Google Scholar]
- Reid I. R. Pathogenesis and treatment of steroid osteoporosis. Clin Endocrinol (Oxf) 1989 Jan;30(1):83–103. doi: 10.1111/j.1365-2265.1989.tb03730.x. [DOI] [PubMed] [Google Scholar]
- Reid I. R. Steroid osteoporosis. Calcif Tissue Int. 1989 Aug;45(2):63–67. doi: 10.1007/BF02561402. [DOI] [PubMed] [Google Scholar]
- Selby P. L., Francis R. M. Endocrinology and osteoporosis. J Endocrinol. 1988 Apr;117(1):1–3. doi: 10.1677/joe.0.1170001. [DOI] [PubMed] [Google Scholar]
- Stellon A. J., Webb A., Compston J. E. Bone histomorphometry and structure in corticosteroid treated chronic active hepatitis. Gut. 1988 Mar;29(3):378–384. doi: 10.1136/gut.29.3.378. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Storm T., Thamsborg G., Steiniche T., Genant H. K., Sørensen O. H. Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. N Engl J Med. 1990 May 3;322(18):1265–1271. doi: 10.1056/NEJM199005033221803. [DOI] [PubMed] [Google Scholar]
- Studd J. W., Savvas M., Johnson M. Correction of corticosteroid-induced osteoporosis by percutaneous hormone implants. Lancet. 1989 Feb 11;1(8633):339–339. doi: 10.1016/s0140-6736(89)91360-3. [DOI] [PubMed] [Google Scholar]